Update on enterovirus 71 infection

Current Opinion in Virology

Volumn 5, Issue 1, 2014, Pages 98-104

  Huang, Peng Nien ^a,b   Shih, Shin Ru ^a,b,c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CAPSID PROTEIN; CARRAGEENAN; CELL RECEPTOR; ENTEROVIRUS 71 VACCINE; HOST FACTOR; NUCLEAR PROTEIN; P SELECTIN GLYCOPROTEIN LIGAND 1; PROTEIN VP1; SCAVENGER RECEPTOR B; SCAVENGER RECEPTOR CLASS B MEMBER 2; TRANS ACTING FACTOR; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARTICLE; AUTOPHAGY; BLEEDING; DRUG RESEARCH; ENCEPHALOMYELITIS; ENTEROVIRUS 71; ENTEROVIRUS 71 INFECTION; ENTEROVIRUS INFECTION; HUMAN; INTERNAL RIBOSOME ENTRY SITE; L CELL; LUNG EDEMA; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; VIRAL TROPISM; VIRUS CAPSID; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS UNCOATING; VIRUS VIRULENCE; ANIMAL; ENTEROVIRUS; GENETICS; METABOLISM; MOUSE; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRULENCE;

ANIMALS; CAPSID PROTEINS; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; HUMANS; MICE; VIRULENCE;

EID: 84898609071     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2014.03.007     Document Type: Review

References (56)

1. N.J. Schmidt, E.H. Lennette, and H.H. Ho An apparently new enterovirus isolated from patients with disease of the central nervous system J Infect Dis 129 1974 304 309
2. A. Hagiwara, I. Tagaya, and T. Yoneyama Epidemic of hand, foot and mouth disease associated (Pubitemid 8199115)
3. T. Solomon, P. Lewthwaite, D. Perera, M.J. Cardosa, P. McMinn, and M.H. Ooi Virology, epidemiology, pathogenesis, and control of enterovirus 71 Lancet Infect Dis 10 2010 778 790
4. K.F. Weng, L.L. Chen, P.N. Huang, and S.R. Shih Neural pathogenesis of enterovirus 71 infection Microbes Infect 12 2010 505 510
5. X. Tan, X. Huang, S. Zhu, H. Chen, Q. Yu, H. Wang, X. Huo, J. Zhou, Y. Wu, and D. Yan et al. The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008 PLoS ONE 6 2011 e25662
6. W. Xing, Q. Liao, C. Viboud, J. Zhang, J. Sun, J.T. Wu, Z. Chang, F. Liu, V.J. Fang, and Y. Zheng et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study Lancet Infect Dis 6 2014 308 318
7. I. Schuffenecker, A. Mirand, D. Antona, C. Henquell, J.J. Chomel, C. Archimbaud, G. Billaud, H. Peigue-Lafeuille, B. Lina, and J.L. Bailly Epidemiology of human enterovirus 71 infections in France, 2000-2009 J Clin Virol 50 2011 50 56
8. S. Kassab, T. Saghi, A. Boyer, M.E. Lafon, D. Gruson, B. Lina, H. Fleury, and I. Schuffenecker Fatal case of enterovirus 71 infection and rituximab therapy, France, 2012 Emerg Infect Dis 19 2013 1345 1347
9. S.A. Badran, S. Midgley, P. Andersen, and B. Bottiger Clinical and virological features of enterovirus 71 infections in Denmark, 2005 to 2008 Scand J Infect Dis 43 2011 642 648
10. M. Cabrerizo, D. Tarrago, C. Munoz-Almagro, E. Del Amo, M. Dominguez-Gil, J.M. Eiros, I. Lopez-Miragaya, C. Perez, J. Reina, and A. Otero et al. Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain Clin Microbiol Infect 20 2013 O150 O156
11. P. Venancio, M. Oliveira, R. Silva, C. Conceicao, and M.J. Brito First case of severe enterovirus 71 infection in Portugal Pediatr Infect Dis J 32 2013 581 582
12. L.M. Lamarao, A.M. Maciel, and M.d.L. Gomes First isolation of enterovirus 71 (EV-71) from Northern Brazil Braz J Infect Dis 7 2003 278 281
13. L. Merovitz, A.M. Demers, D. Newby, and J. McDonald Enterovirus 71 infections at a Canadian center Pediatr Infect Dis J 19 2000 755 757 (Pubitemid 30644048)
14. S. Yamayoshi, Y. Yamashita, J. Li, N. Hanagata, T. Minowa, T. Takemura, and S. Koike Scavenger receptor B2 is a cellular receptor for enterovirus 71 Nat Med 15 2009 798 801
15. Y. Nishimura, M. Shimojima, Y. Tano, T. Miyamura, T. Wakita, and H. Shimizu Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71 Nat Med 15 2009 794 797
16. Y. Nishimura, T. Wakita, and H. Shimizu Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection PLoS Pathog 6 2010 e1001174
17. Y. Nishimura, H. Lee, S. Hafenstein, C. Kataoka, T. Wakita, J.M. Bergelson, and H. Shimizu Enterovirus 71 binding to PSGL-1 on leukocytes: VP 1-145 acts as a molecular switch to control receptor interaction PLoS Pathog 9 2013 e1003511
18. S. Yamayoshi, and S. Koike Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection J Virol 85 2011 4937 4946
19. S. Yamayoshi, S. Iizuka, T. Yamashita, H. Minagawa, K. Mizuta, M. Okamoto, H. Nishimura, K. Sanjoh, N. Katsushima, and T. Itagaki et al. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71 J Virol 86 2012 5686 5696
20. S. Yamayoshi, S. Ohka, K. Fujii, and S. Koike Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71 J Virol 87 2013 3335 3347
21. S.R. Thompson, and P. Sarnow Enterovirus 71 contains a type I IRES element that functions when eukaryotic initiation factor eIF4G is cleaved Virology 315 2003 259 266 (Pubitemid 37340067)
22. E.V. Pilipenko, E.G. Viktorova, S.T. Guest, V.I. Agol, and R.P. Roos Cell-specific proteins regulate viral RNA translation and virus-induced disease EMBO J 20 2001 6899 6908 (Pubitemid 33134219)
23. J.Y. Lin, M.L. Li, and S.R. Shih Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation Nucleic Acids Res 37 2009 47 59
24. L.L. Chen, Y.A. Kung, K.F. Weng, J.Y. Lin, J.T. Horng, and S.R. Shih Enterovirus 71 infection cleaves a negative regulator for viral internal ribosomal entry site-driven translation J Virol 87 2013 3828 3838
25. P.N. Huang, J.Y. Lin, N. Locker, Y.A. Kung, C.T. Hung, H.I. Huang, M.L. Li, and S.R. Shih Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth Nucleic Acids Res 39 2011 9633 9648
26. J.Y. Lin, S.R. Shih, M. Pan, C. Li, C.F. Lue, V. Stollar, and M.L. Li hnRNP A1 interacts with the 5′ untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication J Virol 83 2009 6106 6114
27. Z. Zaini, P. Phuektes, and P. McMinn Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1 Virus Res 167 2012 86 96
28. Z. Zaini, and P. McMinn A single mutation in capsid protein VP1 (Q145E) of a genogroup C4 strain of human enterovirus 71 generates a mouse-virulent phenotype J Gen Virol 93 2012 1935 1940
29. S.W. Huang, Y.F. Wang, C.K. Yu, I.J. Su, and J.R. Wang Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement Virology 422 2012 132 143
30. S. Cordey, T.J. Petty, M. Schibler, Y. Martinez, D. Gerlach, S. van Belle, L. Turin, E. Zdobnov, L. Kaiser, and C. Tapparel Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection PLoS Pathog 8 2012 e1002826
31. T.Y. Lin, S.H. Hsia, Y.C. Huang, C.T. Wu, and L.Y. Chang Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system Clin Infect Dis 36 2003 269 274
32. R. Dolin Enterovirus 71 - emerging infections and emerging questions N Engl J Med 341 1999 984 985
33. Y. Zhang, W. Cui, L. Liu, J. Wang, H. Zhao, Y. Liao, R. Na, C. Dong, L. Wang, and Z. Xie et al. Pathogenesis study of enterovirus 71 infection in rhesus monkeys Lab Invest 91 2011 1337 1350
34. J.H. Xiu, H. Zhu, Y.F. Xu, J.N. Liu, X.Z. Xia, and L.F. Zhang Necrotizing myositis causes restrictive hypoventilation in a mouse model for human enterovirus 71 infection Virol J 10 2013 215
35. K. Fujii, N. Nagata, Y. Sato, K.C. Ong, K.T. Wong, S. Yamayoshi, M. Shimanuki, H. Shitara, C. Taya, and S. Koike Transgenic mouse model for the study of enterovirus 71 neuropathogenesis Proc Natl Acad Sci U S A 110 2013 14753 14758
36. Y.W. Lin, S.L. Yu, H.Y. Shao, H.Y. Lin, C.C. Liu, K.N. Hsiao, E. Chitra, Y.L. Tsou, H.W. Chang, and C. Sia et al. Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71 PLoS ONE 8 2013 e57591
37. Y.P. Li, Z.L. Liang, Q. Gao, L.R. Huang, Q.Y. Mao, S.Q. Wen, Y. Liu, W.D. Yin, R.C. Li, and J.Z. Wang Safety and immunogenicity of a novel human enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial Vaccine 30 2012 3295 3303
38. C.W. Chang, Y.L. Leu, and J.T. Horng Daphne Genkwa sieb. Et zucc. Water-soluble extracts act on enterovirus 71 by inhibiting viral entry Viruses 4 2012 539 556
39. Y.H. Chiu, Y.L. Chan, L.W. Tsai, T.L. Li, and C.J. Wu Prevention of human enterovirus 71 infection by kappa carrageenan Antiviral Res 95 2012 128 134
40. P. Plevka, R. Perera, M.L. Yap, J. Cardosa, R.J. Kuhn, and M.G. Rossmann Structure of human enterovirus 71 in complex with a capsid-binding inhibitor Proc Natl Acad Sci U S A 110 2013 5463 5467
41. P. Plevka, R. Perera, J. Cardosa, R.J. Kuhn, and M.G. Rossmann Crystal structure of human enterovirus 71 Science 336 2012 1274
42. L. De Colibus, X. Wang, J.A. Spyrou, J. Kelly, J. Ren, J. Grimes, G. Puerstinger, N. Stonehouse, T.S. Walter, and Z. Hu et al. More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules Nat Struct Mol Biol 21 2014 282 288
43. P. Plevka, P.Y. Lim, R. Perera, J. Cardosa, A. Suksatu, R.J. Kuhn, and M.G. Rossmann Neutralizing antibodies can initiate genome release from human enterovirus 71 Proc Natl Acad Sci U S A 111 2014 2134 2139
44. N. Falah, R. Montserret, V. Lelogeais, I. Schuffenecker, B. Lina, J.C. Cortay, and S. Violot Blocking human enterovirus 71 replication by targeting viral 2A protease J Antimicrob Chemother 67 2012 2865 2869
45. C.W. Tan, Y.F. Chan, K.M. Sim, E.L. Tan, and C.L. Poh Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1 PLoS ONE 7 2012 e34589
46. J.X. Deng, X.J. Nie, Y.F. Lei, C.F. Ma, D.L. Xu, B. Li, Z.K. Xu, and G.C. Zhang The highly conserved 5′ untranslated region as an effective target towards the inhibition of enterovirus 71 replication by unmodified and appropriate 2′-modified siRNAs J Biomed Sci 19 2012 73
47. J. Xu, Y. Qian, S. Wang, J.M. Serrano, W. Li, Z. Huang, and S. Lu EV71: an emerging infectious disease vaccine target in the Far East? Vaccine 35 28 2010 6 3521
48. J. Qiu Enterovirus 71 infection: a new threat to global public health? Lancet Neurol 7 2008 868 869
49. F.C. Zhu, F.Y. Meng, J.X. Li, X.L. Li, Q.Y. Mao, H. Tao, Y.T. Zhang, X. Yao, K. Chu, and Q.H. Chen et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Lancet 381 2013 2024 2032
50. F.C. Zhu, Z.L. Liang, X.L. Li, H.M. Ge, F.Y. Meng, Q.Y. Mao, Y.T. Zhang, Y.M. Hu, Z.Y. Zhang, and J.X. Li et al. Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial Lancet 381 2013 1037 1045
51. Z. Liang, Q. Mao, Q. Gao, X. Li, C. Dong, X. Yu, X. Yao, F. Li, W. Yin, and Q. Li et al. Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines Vaccine 29 2011 9668 9674
52. R. Li, L. Liu, Z. Mo, X. Wang, J. Xia, Z. Liang, Y. Zhang, Y. Li, Q. Mao, and J. Wang et al. An inactivated enterovirus 71 vaccine in healthy children N Engl J Med 370 2014 829 837
53. Y.C. Chung, M.S. Ho, J.C. Wu, W.J. Chen, J.H. Huang, S.T. Chou, and Y.C. Hu Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge Vaccine 26 2008 1855 1862
54. Y.L. Lin, C.I. Yu, Y.C. Hu, T.J. Tsai, Y.C. Kuo, W.K. Chi, A.N. Lin, and B.L. Chiang Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles Vaccine 30 2012 1305 1312
55. Y.C. Chung, J.H. Huang, C.W. Lai, H.C. Sheng, S.R. Shih, M.S. Ho, and Y.C. Hu Expression, purification and characterization of enterovirus-71 virus-like particles World J Gastroenterol 12 2006 921 927
56. H.Y. Li, J.F. Han, C.F. Qin, and R. Chen Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice Vaccine 31 2013 3281 3287